Dephosphorylation of specific sites in the kinase-specificity sequence domain leads to ubiquitin-mediated degradation of the tyrosine phosphatase STEP.
Dephosphorylation of specific sites in the kinase-specificity sequence domain leads to ubiquitin-mediated degradation of the tyrosine phosphatase STEP.
复制标题
DOI:
10.1042/bj20110240
复制
发表时间:
2011-11-15
期刊:
影响因子:
--
通讯作者:
Paul S
中科院分区:
文献类型:
--
作者:
Mukherjee S;Poddar R;Deb I;Paul S
Striatal-enriched phosphatase (STEP) is a non-receptor tyrosine phosphatase that is specifically expressed in neurons of the central nervous system. STEP regulates the activity of several effector molecules involved in synaptic plasticity and neuronal cell survival, including mitogen-activated protein kinases (MAPKs), Src family kinases and N-methyl-D-aspartic acid (NMDA) receptors. The critical role of STEP in regulating these effectors requires that its activity be tightly regulated. Previous studies demonstrated that the activity of STEP is regulated through reversible phosphorylation of a serine residue within the kinase interacting motif (KIM), by cAMP-dependent protein kinase A (PKA). Here we show that STEP is endogenously phosphorylated at two additional sites located within the kinase specificity sequences (KIS). Basal activity of ERK and p38 MAPKs plays an important role in the phosphorylation of these two sites. Dephosphorylation of these two sites leads to poly-ubiquitination and proteolytic degradation of STEP. Conversely, the proteasome inhibitors MG-132 and epoxomicin can stabilize STEP. The active form of STEP is more susceptible to degradation than the inactive form. Taken together our results establish that ubiquitin-dependent proteolysis could be a novel mechanism for terminating the activity of STEP irreversibly.